Efficiency of Facial Expression Diagnostic System in Pain Assessment After Geriatric Surgery
Launched by ZONGULDAK BULENT ECEVIT UNIVERSITY · Mar 2, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to assess pain in older adults after they have surgery. Researchers want to see if a facial expression diagnostic system can accurately measure pain compared to the pain scores reported by patients and nurses. The goal is to find out if the system can help healthcare providers better understand how much pain patients are experiencing after surgery, which is important for ensuring they receive the right care.
To be eligible for this study, participants must be 65 years or older, awake and oriented after surgery, and not discharged within the first 24 hours. They should also have mild to moderate systemic health issues, as classified by the American Society of Anesthesiologists. If someone is interested in joining, they can expect to have their pain assessed through both traditional methods and this new facial expression analysis, helping to improve pain management for older adults in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient is 65 years or older,
- • According to the American Society of Anesthesiologists (ASA) classification; Being in class -II and III; ASA II: Patient with mild systemic disease, ASA III: Patient with severe systemic disease but not affecting activities of daily living.
- • Willingness to participate in the research,
- • The patient is awake and oriented after the surgery,
- • The patient is not discharged within the first 24 hours after the operation,
- Exclusion Criteria:
- • Not being willing to participate in the research,
- • The presence of any facial anomalies that may change the facial expression analysis of the patient,
- • The patient's regular use of opiates in the last 6 months,
- • The patient has undergone surgical intervention that requires not being in the prone or semifowler position,
- • The patient is not awake and oriented after the surgery,
- • Discharge of the patient within the first 24 hours after surgery.
About Zonguldak Bulent Ecevit University
Zonguldak Bülent Ecevit University is a distinguished academic institution located in Turkey, dedicated to advancing medical research and education. With a strong emphasis on innovation and collaboration, the university actively sponsors clinical trials that aim to enhance healthcare outcomes and contribute to scientific knowledge. Its multidisciplinary approach fosters a dynamic environment for researchers, clinicians, and students, promoting the development of novel therapeutic interventions and evidence-based practices. Through rigorous ethical standards and a commitment to excellence, Zonguldak Bülent Ecevit University plays a pivotal role in the advancement of medical science and the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zonguldak, Centre, Turkey
Patients applied
Trial Officials
Tülin KURT ALKAN, Expert
Principal Investigator
https://zonguldakataturkdh.saglik.gov.tr/?_Dil=1
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials